WHO recommendations on antenatal care for a positive pregnancy experience

<strong>WHO</strong> <strong>recommendations</strong> on antenatal care for a positive pregnancy experience
141. Preventive chemotherapy in human
helminthiasis: coordinated use of
antihelminthic drugs in control interventions:
a manual for health professionals and
programme managers. Geneva: World Health
Organization; 2006 (http://apps.who.int/iris/
bitstream/10665/43545/1/9241547103_eng.
pdf, accessed 26 September 2016).
142. Salam RA, Haider BA, Humayun Q, Bhutta
ZA. Effect of administration of antihelminthics
for soil-transmitted helminths during
pregnancy. Cochrane Database Syst Rev.
2015;(6):CD005547.
143. Christian P, Khatry SK, West KP, Jr. Antenatal
anthelmintic treatment, birth weight,
and infant survival in rural Nepal. Lancet.
2004;364(9438):981–3.
144. Passerini L, Casey GJ, Biggs BA, Cong DT, Phu LB,
Phuc TQ et al. Increased birth weight associated
with regular pre-pregnancy deworming
and weekly iron-folic acid supplementation
for Vietnamese women. PLoS Negl Trop
Dis. 2012;6(4):e1608. doi:10.1371/journal.
pntd.0001608.
145. de Silva N R, Sirisena JL, Gunasekera DP, Ismail
MM, de Silva HJ. Effect of mebendazole therapy
during pregnancy on birth outcome. Lancet.
1999;353(9159):1145–9.
146. Mondadori E, Ehrhardt A, Le Anh T, Tran Cong
D, Sepe G, Van Huyen N et al. Appreciation of
school deworming program by parents in Ha
Giang Province (Vietnam). Southeast Asian J
Trop Med Public Health. 2006;37:1095–8.
147. Thwaites CL, Loan HT. Eradication of tetanus. Br
Med Bull. 2015;116(1):69–77. doi:10.1093/bmb/
ldv044.
148. Demicheli V, Barale A, Rivetti A. Vaccines
for women for preventing neonatal
tetanus. Cochrane Database Syst Rev.
2015;(7):CD002959.
149. Blencowe H, Lawn J, Vandelaer J, Roper M,
Cousens S. Tetanus toxoid immunization to
reduce mortality from neonatal tetanus. Int J
Epidemiol. 2010;39(Suppl 1):i102-i109.
150. Statement on tetanus toxoid vaccine. Geneva:
World Health Organization; 2014 (http://www.
who.int/immunization/statement_on_tetanus_
toxoid_vaccine.pdf, accessed 25 June 2016).
151. Wolfson LJ, Gasse F, Lee-Martin S-P, Lydon
P, Magan A, Tibouti A et al. Estimating the
costs of achieving the <strong>WHO</strong>–UNICEF Global
Immunization Vision and Strategy, 2006–2015.
Bull World Health Organ. 2008;86(1):27–39.
152. Mvundura M, Kien VD, Nga NT, Robertson J,
Cuong NV, Tung HT et al. How much does it cost
to get a dose of vaccine to the service delivery
location? Empirical evidence from Vietnam’s
Expanded Program on Immunization. Vaccine.
2014;32:834–8.
153. Guidelines for the treatment of malaria,
third edition. Geneva: World Health
Organization; 2015 (http://apps.who.int/iris/
bitstream/10665/162441/1/9789241549127_
eng.pdf, accessed 28 September 2016).
154. Kayentao K, Garner P, van Eijk AM, Naidoo
I, Roper C, Mulokozi A et al. Intermittent
preventive therapy for malaria during pregnancy
using 2 vs 3 or more doses of sulfadoxine–
pyrimethamine and risk of low birth weight in
Africa: systematic review and meta-analysis.
JAMA. 2013;309:594–604.
155. Roll Back Malaria Partnership Malaria in
Pregnancy Working Group. Consensus
statement on folic acid supplementation during
pregnancy. Geneva; 2015 (https://www.pmi.gov/
docs/default-source/default-document-library/
tools-curricula/consensus-statement-folicacid-supplementation-during-pregnancy.pdf,
accessed 26 September 2016).
156. Einarson TR, Piwko C, Koren G. Quantifying
the global rates of nausea and vomiting of
pregnancy: a meta analysis. J Popul Ther Clin
Pharmacol. 2013;20(2):e171–83.
157. Matthews A, Haas DM, O’Mathúna DP,
Dowswell T. Interventions for nausea and
vomiting in early pregnancy. Cochrane Database
Syst Rev. 2015;(9):CD007575.
132